Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-12 Sale |
2024-08-14 4:57 pm |
HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director |
29,881 | $56.53 | $1,689,294 | 69,874 (Direct) |
View |
| 2024-06-11 Sale |
2024-06-13 4:15 pm |
HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director |
20,000 | $50.31 | $1,006,300 | 99,755 (Direct) |
View |
| 2022-12-02 Sale |
2022-12-06 7:07 pm |
HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director |
30,000 | $56.88 | $1,706,550 | 105,189 (Direct) |
View |
| 2021-11-30 Purchase |
2021-12-01 9:41 pm |
Nautilus Biotechnology Inc. | NAUT | Posard Matthew L. Director |
50,000 | $4.5101 | $225,505 | 150,000 (Indirect Direct) |
View |
| 2021-02-17 Purchase |
2021-02-19 6:13 pm |
Talis Biomedical Corp | TLIS | Posard Matthew L. Director |
62,500 | $16 | $1,000,000 | 62,500 (Direct) |
View |
| 2021-01-11 Purchase |
2021-01-13 4:21 pm |
DermTech Inc. | DMTK | Posard Matthew L. Director |
33,898 | $29.5 | $999,991 | 86,863 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-14 Option Award |
2024-06-17 5:03 pm |
N/A 2034-06-14 |
Nautilus Biotechnology Inc. | NAUT | Posard Matthew L. Director |
45,000 | $0 | 45,000 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 6:11 pm |
N/A 2034-04-25 |
HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director |
15,305 | $0 | 128,559 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-16 7:52 pm |
N/A 2033-06-15 |
Nautilus Biotechnology Inc. | NAUT | Posard Matthew L. Director |
45,000 | $0 | 45,000 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-12 5:28 pm |
N/A 2033-06-09 |
Talis Biomedical Corp | TLIS | Posard Matthew L. Director |
95,000 | $0 | 95,000 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 6:20 pm |
N/A N/A |
DermTech Inc. | DMTK | Posard Matthew L. Director |
35,714 | $0 | 158,215 (Direct) |
View |
| 2023-05-05 Option Award |
2023-05-09 6:27 pm |
2024-05-05 2033-05-05 |
HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director |
19,436 | $0 | 124,625 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 8:04 pm |
N/A 2032-06-15 |
Nautilus Biotechnology Inc. | NAUT | Posard Matthew L. Director |
86,467 | $0 | 86,467 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 5:41 pm |
N/A 2032-06-09 |
Talis Biomedical Corp | TLIS | Posard Matthew L. Director |
95,000 | $0 | 95,000 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-31 8:11 pm |
N/A N/A |
DermTech Inc. | DMTK | Posard Matthew L. Director |
26,480 | $0 | 122,501 (Direct) |
View |
| 2022-05-05 Option Award |
2022-05-06 8:07 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director |
6,206 | $0 | 135,189 (Direct) |
View |
Ownership |
2021-06-09 9:38 pm |
N/A N/A |
Nautilus Biotechnology Inc. | NAUT | Posard Matthew L. Director |
0 | $0 | 368,476 (Indirect) |
View |
| 2021-05-26 Option Award |
2021-05-28 8:19 pm |
N/A N/A |
DermTech Inc. | DMTK | Posard Matthew L. Director |
9,158 | $0 | 96,021 (Direct) |
View |
| 2021-05-05 Option Award |
2021-05-06 8:04 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director |
5,230 | $0 | 128,983 (Direct) |
View |
Ownership |
2021-02-11 7:13 pm |
N/A 2030-02-11 |
Talis Biomedical Corp | TLIS | Posard Matthew L. Director |
0 | $0 | 143,779 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:19 pm |
N/A N/A |
DermTech Inc. | DMTK | Posard Matthew L. Director |
8,000 | $0 | 52,965 (Direct) |
View |
| 2020-04-30 Option Award |
2020-05-01 7:15 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director |
8,829 | $0 | 123,753 (Direct) |
View |
| 2020-04-29 Exercise |
2020-05-01 4:24 pm |
N/A 2026-09-21 |
DermTech Inc. | DMTK | Posard Matthew L. Director |
9,702 | $0 | 44,965 (Direct) |
View |
| 2020-04-29 Exercise |
2020-05-01 4:24 pm |
N/A N/A |
DermTech Inc. | DMTK | Posard Matthew L. Director |
9,702 | $6.94 | 44,965 (Direct) |
View |